Phytochemicals approach for Developing cancer immunotherapeutics

Shu Yi Yin, Ning Sun Yang, Tien Jen Lin

Research output: Contribution to journalShort surveypeer-review

38 Citations (Scopus)


Phytochemicals or their derived compounds are being increasingly recognized as potentially potent complementary treatments for cancer. Among them, some phytochemicals are being actively evaluated for use as adjuvants in anticancer therapies. For instance, shikonin and hypericin were found to induce immunogenic cell death of specific cancer cells, and this effect was able to further activate the recognition activity of tumor cells by the host immune system. On the other hand, some derivatives of phytochemicals, such as dihydrobenzofuran lignan (Q2-3) have been found to induce the secretion of an endogenous anticancer factor, namely IL-25, from non-malignant cells. These findings suggest that phytochemicals or their derivatives confer a spectrum of different pharmacological activities, which contrasts with the current cytotoxic anticancer drugs commonly used in clinics. In this review, we have collected together pertinent information from recent studies about the biochemical and cellular mechanisms through which specific phytochemicals regulate target immune systems in defined tumor microenvironments. We have further highlighted the potential application of these immunotherapeutic modifiers in cell-based cancer vaccine systems. This knowledge provides useful technological support and know how for future applications of phytochemicals in cancer immunotherapy.

Original languageEnglish
Article number386
JournalFrontiers in Pharmacology
Issue numberJUN
Publication statusPublished - 2017


  • Cancer immunotherapy
  • Herbal extract
  • Phytochemicals
  • Tumor microenvironment

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Phytochemicals approach for Developing cancer immunotherapeutics'. Together they form a unique fingerprint.

Cite this